CDC73 and neoplasm: Given the fact that subsets of patients with seemingly sporadic parathyroid carcinoma have been found to carry germline inactivating mutations of the HRPT2 gene [13], an observation of reduced parafibromin expression in a tumour sample could motivate HRPT2 mutation analysis in the afflicted patient to exclude a possible hereditary background.